Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

469 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose chemotherapy for solid tumors: results of the EBMT.
Rosti G, Ferrante P, Ledermann J, Leyvraz S, Ladenstein R, Koscileniak E, Crown J, Dazzi C, Cariello A, Marangolo M. Rosti G, et al. Crit Rev Oncol Hematol. 2002 Feb;41(2):129-40. doi: 10.1016/s1040-8428(01)00150-0. Crit Rev Oncol Hematol. 2002. PMID: 11856589 Review.
High-dose chemotherapy in adult patients with germ cell tumors.
De Giorgi U, Papiani G, Severini G, Fiorentini G, Marangolo M, Rosti G. De Giorgi U, et al. Among authors: rosti g. Cancer Control. 2003 Jan-Feb;10(1):48-56. doi: 10.1177/107327480301000106. Cancer Control. 2003. PMID: 12598855 Free article. Review.
Prevention and therapy of neutropenia in elderly patients.
Rosti G, Kopf B, Cariello A, Monti M, Dazzi C, Papiani G, Giovanis P, De Giorgi U, Marangolo M. Rosti G, et al. Crit Rev Oncol Hematol. 2003 Jun;46(3):247-53. doi: 10.1016/s1040-8428(03)00024-6. Crit Rev Oncol Hematol. 2003. PMID: 12791424 Review.
High dose chemotherapy in germ cell tumors.
Rosti G, De Giorgi U. Rosti G, et al. Tunis Med. 2005 Dec;83 Suppl 12:85-6. Tunis Med. 2005. PMID: 16430076 Review. No abstract available.
Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer.
De Giorgi U, Giannini M, Frassineti L, Kopf B, Palazzi S, Giovannini N, Zumaglini F, Rosti G, Emiliani E, Marangolo M. De Giorgi U, et al. Among authors: rosti g. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1165-9. doi: 10.1016/j.ijrobp.2006.02.018. Epub 2006 May 6. Int J Radiat Oncol Biol Phys. 2006. PMID: 16682141 Clinical Trial.
469 results